SaverOne 2014 shares were up 59% pre-bell Monday following a muted session.Sonnet BioTherapeutics shares were 31% higher after a 5.5% loss in the previous session.Apogee Therapeutics stock was up 20% after the company said that part A of a phase 2 trial of APG777 in patients with moderate-to-severe atopic dermatitis met all primary and key secondary endpoints.